CAS 98319-26-7
:Finasterida
Descripción:
Finasterida es un compuesto farmacéutico sintético utilizado principalmente en el tratamiento de la hiperplasia prostática benigna (HPB) y la alopecia androgenética (calvicie de patrón masculino). Funciona como un inhibidor de la 5-alfa-reductasa, bloqueando la conversión de testosterona a dihidrotestosterona (DHT), una hormona implicada en ambas condiciones. La fórmula molecular de Finasterida es C23H36N2O2, y tiene un peso molecular de aproximadamente 372.55 g/mol. La sustancia aparece como un polvo cristalino blanco a blanco amarillento y se administra típicamente por vía oral. Finasterida es conocido por su relativamente alta biodisponibilidad y se metaboliza principalmente en el hígado. Los efectos secundarios comunes pueden incluir disfunción sexual, ginecomastia y cambios de humor, aunque no todos los usuarios los experimentan. Debido a su mecanismo de acción, Finasterida está contraindicado en mujeres, particularmente durante el embarazo, ya que puede causar daño fetal. En general, Finasterida es un medicamento significativo en urología y dermatología, proporcionando beneficios terapéuticos para condiciones relacionadas con la DHT.
Fórmula:C23H36N2O2
InChI:InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1
Clave InChI:InChIKey=DBEPLOCGEIEOCV-WSBQPABSSA-N
SMILES:C[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@@](CC3)(NC(=O)C=C4)[H])(CC1)[H])[H])(CC[C@@H]2C(NC(C)(C)C)=O)[H]
Sinónimos:- (4aR,4bS,6aS,7S,9aS,9bS)-N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-Dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide
- (4aR,4bS,6aS,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-(1,1-dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-
- 4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5α,17β)-
- Appecia
- Chibro-Proscar
- Finalo
- Finara
- Finast
- Finasterid Alternova
- Finastid
- Finax
- Fincar
- Finpecia
- Fistide
- Geffina
- Mk 906
- N-(2-Methyl-2-Propyl)-3-Oxo-4-Aza-5Alpha-Androst-1-Ene-17Beta-Carboxamide
- N-(tert-Butyl)-3-oxo-4-aza-5α-androst-1-ene-17-carboxamide
- Propecia
- Proscar
- Prosteride
- Prostide
- Ver más sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Finasteride
CAS:Fórmula:C23H36N2O2Pureza:>98.0%(GC)Forma y color:White to Almost white powder to crystalPeso molecular:372.55Finasteride
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C23H36N2O2Forma y color:White Off-White PowderPeso molecular:372.27768N-tert-Butyl-3-oxo-4-aza-5α-androst-1-en-17β-carboxamide
CAS:Fórmula:C23H36N2O2Pureza:98%Forma y color:SolidPeso molecular:372.5441Finasteride
CAS:<p>Finasteride (MK-906) is an oral inhibitor of active testosterone 5-alpha-reductase and Ki value is 10 nM.</p>Fórmula:C23H36N2O2Pureza:99.04% - 99.97%Forma y color:White To Off-White Crystalline PowderPeso molecular:372.54Finasteride, USP grade
CAS:Fórmula:C23H36N2O2Pureza:≤ 0.5%Forma y color:White or almost white powderPeso molecular:372.54Finasteride
CAS:Fórmula:C23H36N2O2Pureza:98.5 - 101.0 % (anhydrous basis)Forma y color:White to off-white crystalline powderPeso molecular:372.54Finasteride, EP grade
CAS:Fórmula:C23H36N2O2Pureza:≤ 0.1%Forma y color:White to almost white crystalline powderPeso molecular:372.54Finasteride
CAS:Producto controladoFórmula:C23H36N2O2Forma y color:White To Off-WhitePeso molecular:372.54Finasteride
CAS:<p>Inhibitor of 5α-reductase 5AR2; inhibitor of dihydrotestosterone synthesis</p>Fórmula:C23H36N2O2Pureza:Min. 98 Area-%Forma y color:White Off-White PowderPeso molecular:372.54 g/molFinasteride - Bio-X ™
CAS:<p>Finasteride is an antiandrogenic drug that belongs to the group of 5-alpha reductase inhibitors, which are used for the treatment of benign prostatic hyperplasia and male pattern baldness. The conversion of testosterone to 5α-dihydrotestosterone (DHT) is blocked by type II 5α-reductase inhibition, which then results in significant increase in prostatic testosterone concentrations and minimal to moderate increases in serum and tissue DHT concentrations. A reduction in DHT concentration will cause a reduction in prostatic volume as DHT appears to be the main androgen responsible for stimulating prostatic growth.</p>Fórmula:C23H36N2O2Pureza:Min. 95%Forma y color:PowderPeso molecular:372.54 g/mol















